Lv5
995 积分 2021-07-30 加入
Nanobody-engineered bispecific IL-18 mimetics drive antitumor immunity by engaging CD8+ T cell and evading IL-18BP in preclinical models
11天前
已完结
Re-Evaluating Antibody–Drug Conjugate Linker Stability: Assessment, Interpretation, and Clinical Translation
23天前
已完结
The discovery and evaluation of [18F]BMS-986229, a novel macrocyclic peptide PET radioligand for the measurement of PD-L1 expression and in-vivo PD-L1 target engagement
29天前
已完结
The Regulation and Modification of GSDMD Signaling in Diseases
6个月前
已完结
皖公网安备34019202002308
